FOXA vs VTGN · P/E 14, rev $17.13B vs rev $176.0K
Fox Corp Class A (FOXA) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported FOXA revenue for 2026-06-30 was $17.13B. Net income was $1.73B. Revenue was up 5.1% from 2025-06-30 to 2026-06-30. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
Latest reported VTGN revenue for 2023-03-31 was $176.0K. Net income was -$12.2M. VTGN currently screens at market cap $28.1M.
FOXA currently screens at market cap $24.50B and trailing P/E 14.1. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the FOXA and VTGN stock pages for the full models.
Not investment advice.